Anyone looking to get Plegridy?
Hmu I can help
seen from Kazakhstan

seen from United Kingdom
seen from United States
seen from United States

seen from Singapore

seen from United Kingdom
seen from China

seen from France
seen from China

seen from United States
seen from Finland

seen from United States

seen from Canada
seen from South Korea
seen from Russia

seen from Russia

seen from Australia
seen from Germany

seen from United Kingdom
seen from Canada
Anyone looking to get Plegridy?
Hmu I can help
Plegridy May Win Over MSers with Fewer Injections and Smaller Needles
This week the FDA approved Biogen Idec's new medication, Plegridy, for the treatment of RRMS. I love when new meds come on the market because it means more choices, and hope that research is advancing. Even better, Plegridy comes with improved convenience for many MSers. Plegridy is another interferon medication, joining the ranks of Rebif, Avonex, Betaseron, and Extavia. Biogen Idec thinks Plegridy has the capability of becoming the most popular interferon on the market because it is injected only once every two weeks, and is given subcutaneously which means the needle is smaller then Avonex's. Prior to Plegridy being FDA approved, Avonex (also a Biogen product) was the interferon given the least often- only one injection per week. This was always a stark contrast to Copaxone which was only offered as a daily injection, or other interferons like Rebif which is given three times a week. Recently Copaxone's three times a week formulation was FDA approved, which had many users jumping for joy and my telephone ringing off the hook with people wanting to switch! Many MSers on injectables wouldn't be opposed to getting the same benefits from fewer injections, so is Plegridy really as effective? (read tips on giving injections here)
Another drug that we have to wait for because the FDA is not ready to approve it. This time its Plegidy (peginterferon beta-1a) a interferon med that only needs to be taken once every two week.
Please check out today's post on another drug waiting for the FDA to say okay
(Reuters) - Biogen Idec Inc said the U.S. Food and Drug Administration extended the review process for the company's multiple sclerosis drug by three months to evaluate the application.
The drug is called Plegridy and in 2013 the results were called "excellent" http://www.medicalnewstoday.com/articles/257962.php but now the FDA is saying they need more time to review he findings. I'll have more on this on www.teamfums.org tomorrow.